Reply to: "Can azathioprine prevent infliximab-induced liver injury?"

J Hepatol. 2022 Aug;77(2):555-556. doi: 10.1016/j.jhep.2022.04.006. Epub 2022 Apr 19.

Authors

Helgi Kristinn Björnsson¹, Einar Stefan Björnsson²

Affiliations

¹ Sahlgrenska University Hospital, Department of Internal Medicine, Division of Gastroenterology and Hepatology, Gothenburg, Sweden. Electronic address: helgi.bjornsson@vgregion.se.
² Landspitali - The National University Hospital of Iceland, Division of Gastroenterology and Hepatology, Reykjavik, Iceland; University of Iceland, Faculty of Medicine, Reykjavik, Iceland.

PMID: 35452694
DOI: 10.1016/j.jhep.2022.04.006

No abstract available

Publication types

Letter
Comment

MeSH terms

Azathioprine* / adverse effects
Chemical and Drug Induced Liver Injury, Chronic*
Gastrointestinal Agents
Humans
Immunosuppressive Agents / pharmacology
Infliximab / adverse effects

Substances

Gastrointestinal Agents
Immunosuppressive Agents
Infliximab
Azathioprine